NASDAQ: SINT
Sintx Technologies Inc Stock Forecast, Predictions & Price Target

Analyst price target for SINT

Based on 2 analysts offering 12 month price targets for Sintx Technologies Inc

Min Forecast
$10.00+314.94%
Avg Forecast
$11.00+356.43%
Max Forecast
$12.00+397.93%

Should I buy or sell SINT stock?

Based on 2 analysts offering ratings for Sintx Technologies Inc.

Buy
Strong Buy
0 analysts 0%
Buy
2 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their SINT stock forecasts and price targets.

SINT stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-04-13
lockedlocked$00.00+00.00%2026-04-08

1 of 1

Forecast return on equity

Is SINT forecast to generate an efficient return?

Company
127.75%
Industry
29.18%
Market
166.57%
SINT's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SINT forecast to generate an efficient return on assets?

Company
39.36%
Industry
14.34%
SINT is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SINT earnings per share forecast

What is SINT's earnings per share in the next 3 years based on estimates from 3 analysts?

Avg 1 year Forecast
-$2.17
Avg 2 year Forecast
$0.91
Avg 3 year Forecast
$1.57

SINT revenue forecast

What is SINT's revenue in the next 3 years based on estimates from 4 analysts?

Avg 1 year Forecast
$1.3M+30.26%
Avg 2 year Forecast
$6.8M+568.47%
Avg 3 year Forecast
$26.6M+2,515.13%
SINT's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SINT revenue growth forecast

How is SINT forecast to perform vs Medical Devices companies and vs the US market?

Company
187.25%
Industry
8.81%
Market
13.61%
SINT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SINT's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SINT vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
SINT$2.41$11.00+356.43%Buy
MODD$4.14N/AN/A
VVOS$0.81$2.75+240.77%Buy
TNON$0.78N/AN/A
LFWD$7.25$10.00+38.03%Buy

Sintx Technologies Stock Forecast FAQ

Is Sintx Technologies Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: SINT) stock is to Buy SINT stock.

Out of 2 analysts, 0 (0%) are recommending SINT as a Strong Buy, 2 (100%) are recommending SINT as a Buy, 0 (0%) are recommending SINT as a Hold, 0 (0%) are recommending SINT as a Sell, and 0 (0%) are recommending SINT as a Strong Sell.

If you're new to stock investing, here's how to buy Sintx Technologies stock.

What is SINT's earnings growth forecast for 2026-2030?

(NASDAQ: SINT) Sintx Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 23.16%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 33.82%.

Sintx Technologies's earnings in 2026 is -$17,083,000.On average, 3 Wall Street analysts forecast SINT's earnings for 2026 to be -$8,954,864, with the lowest SINT earnings forecast at -$8,603,693, and the highest SINT earnings forecast at -$9,218,242. On average, 3 Wall Street analysts forecast SINT's earnings for 2029 to be $3,741,704, with the lowest SINT earnings forecast at $3,594,970, and the highest SINT earnings forecast at $3,851,754.

In 2030, SINT is forecast to generate $6,474,409 in earnings, with the lowest earnings forecast at $6,220,510 and the highest earnings forecast at $6,664,833.

What is SINT's revenue growth forecast for 2026-2028?

(NASDAQ: SINT) Sintx Technologies's forecast annual revenue growth rate of 187.25% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.81%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.61%.

Sintx Technologies's revenue in 2026 is $1,018,000.On average, 4 Wall Street analysts forecast SINT's revenue for 2026 to be $5,465,410, with the lowest SINT revenue forecast at $4,443,222, and the highest SINT revenue forecast at $6,491,720. On average, 3 Wall Street analysts forecast SINT's revenue for 2027 to be $28,048,352, with the lowest SINT revenue forecast at $26,947,851, and the highest SINT revenue forecast at $28,872,698.

In 2028, SINT is forecast to generate $109,728,616 in revenue, with the lowest revenue forecast at $105,425,533 and the highest revenue forecast at $112,955,928.

What is SINT's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: SINT) forecast ROA is 39.36%, which is higher than the forecast US Medical Devices industry average of 14.34%.

What is SINT's Price Target?

According to 2 Wall Street analysts that have issued a 1 year SINT price target, the average SINT price target is $11.00, with the highest SINT stock price forecast at $12.00 and the lowest SINT stock price forecast at $10.00.

On average, Wall Street analysts predict that Sintx Technologies's share price could reach $11.00 by Apr 13, 2027. The average Sintx Technologies stock price prediction forecasts a potential upside of 356.43% from the current SINT share price of $2.41.

What is SINT's Earnings Per Share (EPS) forecast for 2026-2030?

(NASDAQ: SINT) Sintx Technologies's current Earnings Per Share (EPS) is -$3.74. On average, analysts forecast that SINT's EPS will be -$2.17 for 2026, with the lowest EPS forecast at -$2.09, and the highest EPS forecast at -$2.24. On average, analysts forecast that SINT's EPS will be $0.91 for 2029, with the lowest EPS forecast at $0.87, and the highest EPS forecast at $0.93. In 2030, SINT's EPS is forecast to hit $1.57 (min: $1.51, max: $1.62).

What is SINT's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: SINT) forecast ROE is 127.75%, which is considered strong.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.